An infant’s death in Chhindwara, Madhya Pradesh, allegedly linked to Ayurvedic medicine consumption, has spurred quick action. The state’s Ayush Department seized the drugs and sent samples for testing, initiating necessary legal procedures. This unfortunate incident highlights the critical need for robust Ayurvedic drug safety measures and ongoing regulatory vigilance in India.
Ensuring Quality and Regulation of Ayush Medicines
The Ministry of Ayush coordinates closely with state authorities. This collaboration aims to maintain high safety and quality standards for Ayush medicines. It also promotes their safe and effective use for public well-being. Furthermore, the Ministry is committed to ensuring strong safety and quality across Ayush medicines. It regularly directs state and Union Territory (UT) governments. This ensures compliance with the Drugs and Cosmetics Act 1940 and Drug Rules, 1945.
Role of State Authorities in Drug Control
State Drug Controllers and State Licensing Authorities enforce legal provisions. They handle quality control and drug license issuance for Ayurveda, Siddha, Unani, Sowa-Rigpa, and Homoeopathy drugs. These authorities, appointed by state and UT governments, play a vital role. They can act decisively against misbranded, adulterated, and spurious Ayush drugs. This protects public health.
Immediate Response in Madhya Pradesh
Following the Chhindwara incident, Madhya Pradesh’s Drug Control Department Ayush responded swiftly. They seized the alleged drugs. Samples were dispatched for testing, alongside other essential legal actions. This immediate response demonstrates a commitment to investigate and address Ayurvedic drug safety concerns.
Broader Pharmacovigilance and Quality Initiatives
India recognizes the growing importance of pharmacovigilance for Ayush drugs. A nationwide program under the Ministry of Ayush detects, assesses, understands, and prevents adverse effects. This program creates a database of Adverse Drug Reactions (ADRs) and develops evidence-based clinical safety recommendations. Manufacturers must adhere to Good Manufacturing Practices (GMP) and comply with quality standards in relevant pharmacopoeias for licensing. The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) sets official pharmacopoeial standards and formulary specifications for drug quality. The Ministry also strengthens state drug testing laboratories and regulatory frameworks. This further enhances Ayurvedic drug safety across the country.
Frequently Asked Questions
Q1: What prompted the recent actions by the Ayush Department in Madhya Pradesh?
The Ayush Department took action following the death of a five-month-old infant in Chhindwara, Madhya Pradesh, allegedly after consuming Ayurvedic medicines. Authorities promptly seized the drugs and sent samples for testing.
Q2: Who regulates the quality of Ayurvedic medicines in India?
Regulation of Ayurvedic medicines falls under the Drugs and Cosmetics Act 1940 and Rules 1945. State Drug Controllers and State Licensing Authorities enforce quality control and issue drug licenses, while the Ministry of Ayush provides overall guidance and coordination.
Q3: What steps does the Ministry of Ayush take to ensure Ayurvedic drug safety?
The Ministry of Ayush coordinates with state authorities, issues directions for compliance with drug laws, supports pharmacovigilance programs, and works to strengthen drug testing laboratories and regulatory frameworks. It also emphasizes adherence to Good Manufacturing Practices (GMP) and pharmacopoeial standards.
References
- MP’s Ayush dept has seized Ayurvedic drugs, sent samples for testing after deathof infant: Ministry – ETHealthworld
- Pharmacovigilance of ayurvedic medicines in India – PMC – NIH
- Infant dies after consuming Ayurvedic cough syrup in MP – NewsBytes
- MP’s Ayush dept has seized Ayurvedic drugs sent samples for testing after death of infant Ministry – The Week
- 6-month-old dies after consuming Ayurvedic syrup in Madhya Pradesh, shop sealed
- Adverse drug reaction and concepts of drug safety in Ayurveda: An overview – PMC
- Quality Control of Ayush Drugs – PIB
- Quality Control | National AYUSH Mission (NAM)
- AYUSH swears by safety of ayurvedic medicines | Ahmedabad News – Times of India
- Another cough syrup tragedy in Madhya Pradesh’s Chhindwara, 5-month-old baby dies
- Infant girl dies after allegedly consuming cough syrup in MP – The Statesman
- PHARMACOVIGILANCE FOR AYURVEDA, SIDDHA, AND UNANI DRUGS: ENSURING SAFETY AND EFFICACY – WJPMR
- AyushSuraksha – AyushSuraksha
- Ministry of AYUSH takes steps to assure quality of AYUSH drugs – Express Pharma
- Assurance of Quality Control of Ayush Drugs – Legality Simplified
- Steps taken to assure quality control of Ayush drugs – PIB
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.